Skip to main content
OpenTrials
Completed

NCT Number: NCT07409909

Total Hip Arthroplasty Versus Bipolar Hemiarthroplasty for Treatment of Intracapsular Displaced Fracture Neck Femur in Elderly Active Patients

Femoral neck fracture (FNF) is a worldwide health problem that can cause significant morbidity and mortality. Most femoral neck fractures are associated with a fall, and the risk factors include osteoporosis, chronic medication use, and reduced level of activity.

Femoral neck fractures are among the most common injuries in the elderly, and their number continues to increase with a more aged population.

In the elderly, femoral neck fractures may lead to significant mortality and morbidity, with impaired mobility and loss of independence. Given their high incidence and associated detrimental effects on patient lives.

The femoral neck fracture is a major type of hip fracture, whose treatment includes internal fixation, hemiarthroplasty (HA), or total hip arthroplasty (THA). The decision depends on multiple variables, including fracture pattern, surgeon comfort, and the patient's age, health, and ambulatory status. Internal fixation is a preferred management option for young people or the elderly who are intolerant of prosthesis surgery. THA and HA are widely used in displaced femoral neck fractures in the elderly. Surgery in these patients is undertaken to facilitate nursing and provide timely pain relief, rapid mobilization, and accelerated rehabilitation In general, HA has the advantages of shorter operation time, less blood loss, less technical demand, less economic burden, and a lower dislocation rate. However, some patients treated with HA require conversion to THA due to complications such as acetabular erosion.

THA, on the other hand, has been associated with superior patient satisfaction and better hip function, less acetabular erosion, and a lower revision rate. However, increased surgical complexity, operation time, and blood loss, as well as higher dislocation rates in THA for FNFs, remain a concern

Completed

Looking for future studies?

Notify Me

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Medicine, for Girls, Al-Zhar University, Egpyt

Cairo, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • were aged ≥ 65 years
  • with a displaced intracapsular fracture of the femoral neck (Garden type III, IV).

Exclusion criteria

  • extracapsular fracture of the femoral neck
  • Pathological fractures, or open fractures
  • Active infections at or near the hip joints.
  • bedridden, immobile, or cognitively impaired patients
  • patients with associated pelvic or acetabular fractures

Treatment and study plan

Total Hip Arthroplasty

Procedure

Patients will have total hip arthroplasty for managing neck femur fracture

Bipolar hemiarthroplasty

Procedure

Patients in the control group with femur fracture will have bipolar hemiarthroplasty

Primary outcomes

  1. functional improvement

    Time frame: 12 months

    will be assessed via modified Harris Hip Score. The score is calculated based on four parameters: pain (0-44 points), function (0-47 points), absence of deformity (0-4 points), and range of motion (0-5 points).

Sponsors and collaborators

Lead sponsor

Al-Azhar University

Other

Registry information

Official study title

Total Hip Arthroplasty Versus Bipolar Hemiarthroplasty for Treatment of Intracapsular Displaced Fracture Neck Femur in Elderly Active Patients; Single-center Randomized Controlled Trial

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Feb 13, 2026
Registry last updated
Feb 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.